Oscar Health, Inc. carries a market capitalization of 7.76B, placing it among publicly traded companies globally. Its enterprise value stands at -3.22B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.76B |
| Enterprise Value | -3.22B |
Oscar Health, Inc. currently has 299.14M shares outstanding.
| Shares Outstanding | 299.14M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.24, and the price-to-book ratio stands at -1.20.
| PE Ratio | N/A |
| PS Ratio | 0.24 |
| PB Ratio | -1.20 |
| P/TBV Ratio | 1.89 |
| P/FCF Ratio | 1.13 |
| P/OCF Ratio | 1.11 |
| EV / Sales | 0.48 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 5.33 |
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | 25.85 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -0.52 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 0.82 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Oscar Health, Inc. has paid 12.65M in income taxes, reflecting an effective tax rate of 2.83.
| Income Tax | 12.65M |
| Effective Tax Rate | 2.83 |
Oscar Health, Inc.'s stock has gained approximately 46.57199% over the past 52 weeks. The 50-day moving average sits at 21.61, while the 200-day moving average is 17.42.
| Beta (5Y) | N/A |
| 52-Week Price Change | 46.57199% |
| 50-Day Moving Average | 21.61 |
| 200-Day Moving Average | 17.42 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Oscar Health, Inc. generated 13.30B in revenue and converted that into -39.43M in net income, yielding earnings per share of -0.14.
| Revenue | 13.30B |
| Gross Profit | N/A |
| Operating Income | N/A |
| Pretax Income | -26.73M |
| Net Income | -39.43M |
| EBITDA | N/A |
| EBIT | N/A |
| Earnings Per Share (EPS) | -0.14 |
Oscar Health, Inc. holds 6.80B in cash and equivalents against 430.88M in total debt, resulting in a net debt position of -4.37B.
| Cash & Cash Equivalents | 6.80B |
| Total Debt | 430.88M |
| Net Debt | -4.37B |
| Equity (Book Value) | -2.62B |
| Book Value Per Share | -9.54 |
| Working Capital | N/A |
Oscar Health, Inc. produced 2.84B in operating cash flow over the past twelve months. After subtracting -36.14M in capital expenditures, free cash flow totaled 2.80B - equivalent to 10.21 per share.
| Operating Cash Flow | 2.84B |
| Capital Expenditures | -36.14M |
| Free Cash Flow | 2.80B |
| FCF Per Share | 10.21 |
Oscar Health, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics.
| Gross Margin | 100.00 |
| Operating Margin | N/A |
| Pretax Margin | -0.20 |
| Profit Margin | -0.30 |
| EBITDA Margin | N/A |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -12.43 |
| FCF Yield | 88.79 |
Oscar Health, Inc. posts an Altman Z-Score of 1.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.29 |